. Epinephrine promotes pulmonary angiitis: evidence for a 1-adrenoreceptor-mediated mechanism. Am J Physiol Lung Cell Mol Physiol 285: L232-L239, 2003; 10.1152/ajplung.00248.2002 increases lymphocyte traffic to lung. We investigated whether Epi also modulates pulmonary cell-mediated immune responses in vivo. C57BL/6 mice were immunized with hen-egg lysozyme (HEL) on day 0, challenged with HEL intratracheally at day 12, and killed at day 15. Mice received Epi (0.5 mg/kg) subcutaneously during the sensitization phase, days 1-7 (Epi-SP), or the effector phase, days 12-14 (Epi-EP); controls received saline subcutaneously. Epi-SP mice showed increased airway inflammation (P Ͻ 0.03) and pulmonary angiitis (P Ͻ 0.04) characterized by endothelialitis and subendothelial fibrin deposition. Macrophages and granulocytes were increased in perivascular cuffs in situ (P Ͻ 0.001). CD3 ϩ lymphocytes increased in the bronchoalveolar lavage fluid, whereas NK1.1 ϩ and CD4 ϩ CD25 ϩ lymphocytes decreased (all P Ͻ 0.05). Atenolol, a selective 1-adrenoreceptor (AR) antagonist, inhibited the increased vascular and airway inflammation and the reduction in CD4 ϩ CD25 ϩ lymphocytes (all P Ͻ 0.05) yielded by Epi, whereas all ␣/-AR blockers inhibited airway inflammation. We conclude that Epi-EP selectively promotes vascular inflammation in vivo via a  1-receptor-mediated mechanism.